WFRF:(Walley A.)
Sökning: WFRF:(Walley A.) > Utilisation of anti...
Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels.
-
- Melander, Arne (författare)
- Lund University,Lunds universitet,Allmänmedicin och samhällsmedicin,Forskargrupper vid Lunds universitet,Samhällsmedicin,Family Medicine and Community Medicine,Lund University Research Groups,Community Medicine
- Folino-Gallo, P (författare)
- Walley, T (författare)
- visa fler...
- Schwabe, U (författare)
- Groop, P-H (författare)
- Klaukka, T (författare)
- Vallano, A (författare)
- Laporte, J-R (författare)
- Gallego, M (författare)
- Schiappa, M (författare)
- Røder, M (författare)
- Kampmann, J (författare)
- de Swaef, A (författare)
- visa färre...
- (creator_code:org_t)
- 2006-07-25
- 2006
- Engelska.
- Ingår i: Diabetologia. - : Springer Science and Business Media LLC. - 1432-0428 .- 0012-186X. ; 49:9, s. 2024-2029
- Tidskriftsartikel (refereegranskat)
Abstract
Ämnesord
Stäng
- Aims/hypothesis The aim of this study was to compare developments in the utilisation of antihyperglycaemic drugs (AHGDs) in ten European countries. Subhect and methods Data on the yearly utilisation of insulin and oral AHGDs were collected from public registers in Denmark, Finland, Norway, Sweden, Belgium, England, Germany, Italy, Portugal and Spain, and were expressed as defined daily doses per 1,000 inhabitants per day. Results Total AGHD utilisation increased everywhere, but at different rates and levels. Insulin utilisation doubled in England and Germany, but hardly changed in Belgium, Portugal or Italy. Sulfonylurea utilisation doubled in Spain, England and Denmark but was reduced in Germany and Sweden. Metformin utilisation increased greatly everywhere. There were two- to three-fold differences in AHGD utilisation even between neighbouring countries. In Finland, there were more users of both insulin (+120%) and oral AHGDs (+80%) than in Denmark, and the daily oral AHGD doses were higher. In Denmark and Sweden, AHGD utilisation was equal in subjects aged < 45 years, but in those >= 45 years of age, both insulin and oral AHGD utilisation were twice as high in Sweden. Conclusions/interpretation The ubiquitous increase in AHGD utilisation, particularly metformin, seems logical, considering the increasing prevalence of type 2 diabetes and the results of the UK Prospective Diabetes Study. However, the large differences even between neighbouring countries are more difficult to explain, and suggest different habits and attitudes in terms of screening and management of type 2 diabetes.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
Nyckelord
- insulin
- international comparison
- metformin (biguanides)
- international
- diabetes mellitus
- treatment of diabetes
- antihyperglycaemic drug utilisation
- sulfonylurea
- variation in drug utilisation
- antidiabetic drug utilisation
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta mer i SwePub
- Av författaren/redakt...
- Melander, Arne
- Folino-Gallo, P
- Walley, T
- Schwabe, U
- Groop, P-H
- Klaukka, T
- visa fler...
- Vallano, A
- Laporte, J-R
- Gallego, M
- Schiappa, M
- Røder, M
- Kampmann, J
- de Swaef, A
- Åberg, Magnus
- Månsson, Nils-Ov ...
- Lindblad, Ulf
- visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
- MEDICIN OCH HÄLS ...
- och Klinisk medicin
- och Endokrinologi oc ...
- Artiklar i publikationen
- Diabetologia
- Av lärosätet
- Lunds universitet
Sök utanför SwePub
- Sök vidare i:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - Nationella bibliotekssystem
- LIBRIS.kb.se
